相似文献
1
Aggressive squamous cell carcinoma of the oral tongue in a woman with metastatic giant cell tumor treated with pegylated liposomal doxorubicin.
Oncologist. 2012;17(12):1596-7. doi: 10.1634/theoncologist.2012-0429.
2
Squamous cell carcinoma of the oral tongue in two patients previously exposed to long-term pegylated liposomal doxorubicin.
Oncologist. 2012;17(12):1594-5. doi: 10.1634/theoncologist.2011-0280. Epub 2012 May 23.
3
Long-term pegylated liposomal doxorubicin use and oromaxillary squamous cell carcinoma in endometrial cancer.
Oncologist. 2012;17(12):1598-9. doi: 10.1634/theoncologist.2012-0358.
4
Squamous cell carcinoma of the oral cavity in a woman with a 9-year history of ovarian cancer: is exposure to pegylated liposomal Doxorubicin a factor?
Oncologist. 2014 Apr;19(4):429. doi: 10.1634/theoncologist.2013-0421. Epub 2014 Mar 25.
5
Oral squamous cell carcinoma in a patient treated with long-term pegylated liposomal doxorubicin for recurrent ovarian cancer.
BMJ Case Rep. 2015 Jan 14;2015:bcr2014204056. doi: 10.1136/bcr-2014-204056.
6
Development of cutaneous squamous cell carcinoma after prolonged exposure to pegylated liposomal doxorubicin and hand-foot syndrome: a newly recognized toxicity.
Cancer Chemother Pharmacol. 2019 Jul;84(1):217-221. doi: 10.1007/s00280-019-03849-8. Epub 2019 Apr 30.
7
Squamous cell carcinoma of the oral cavity in nonsmoking women: a new and unusual complication of chemotherapy for recurrent ovarian cancer?
Oncologist. 2012;17(12):1541-6. doi: 10.1634/theoncologist.2011-0216. Epub 2012 May 23.
8
Squamous cell carcinomas of the tongue and oral cavity as secondary malignancies: what factors are implicated?
Oncologist. 2013;18(3):245-7. doi: 10.1634/theoncologist.2013-0021. Epub 2013 Mar 13.
9
Pegylated liposomal doxorubicin is active in Stewart-Treves syndrome.
Ann Oncol. 2007 May;18(5):959-60. doi: 10.1093/annonc/mdm113.
10
"Skin problems associated with pegylated liposomal doxorubicin -- more than palmoplantar erythrodysesthesia syndrome".
Eur J Dermatol. 2009 May-Jun;19(3):264-5. doi: 10.1684/ejd.2009.0630. Epub 2009 Feb 12.
引用本文的文献
1
A case of tongue cancer manifesting from oral leukoplakia after long-term administration of pegylated liposomal doxorubicin.
Oxf Med Case Reports. 2022 Apr 19;2022(4):omac042. doi: 10.1093/omcr/omac042. eCollection 2022 Apr.
2
Oral leukoplakia, a precancerous lesion of squamous cell carcinoma, in patients with long-term pegylated liposomal doxorubicin treatment.
Medicine (Baltimore). 2018 Feb;97(7):e9932. doi: 10.1097/MD.0000000000009932.
3
Oral squamous cell carcinoma in a patient treated with long-term pegylated liposomal doxorubicin for recurrent ovarian cancer.
BMJ Case Rep. 2015 Jan 14;2015:bcr2014204056. doi: 10.1136/bcr-2014-204056.
4
Squamous cell carcinoma of the oral cavity in a woman with a 9-year history of ovarian cancer: is exposure to pegylated liposomal Doxorubicin a factor?
Oncologist. 2014 Apr;19(4):429. doi: 10.1634/theoncologist.2013-0421. Epub 2014 Mar 25.
5
Squamous cell carcinomas of the tongue and oral cavity as secondary malignancies: what factors are implicated?
Oncologist. 2013;18(3):245-7. doi: 10.1634/theoncologist.2013-0021. Epub 2013 Mar 13.
本文引用的文献
1
Squamous cell carcinoma of the oral cavity in nonsmoking women: a new and unusual complication of chemotherapy for recurrent ovarian cancer?
Oncologist. 2012;17(12):1541-6. doi: 10.1634/theoncologist.2011-0216. Epub 2012 May 23.
2
Does long-term treatment with Doxil® predispose patients to oral cancer?
Int J Clin Oncol. 2013 Jun;18(3):554-5. doi: 10.1007/s10147-012-0400-1. Epub 2012 Mar 20.
Zotero 插件